期刊文献+

骨皮质切开加速大鼠正畸牙移动的机制研究 被引量:7

The mechanism of corticotomy accelerating orthodontic tooth movement in SD rats
下载PDF
导出
摘要 目的 :研究骨皮质切开术加速大鼠正畸牙移动的组织学改建机制。方法 :选用健康未孕雌性Sprague-Dawley(S-D)大鼠48只,随机分为骨皮质切开手术组和对照组。在手术组大鼠行骨皮质切开术,对照组大鼠行对照手术后,构建正畸牙移动模型。在牙移动0、1、3、7 d分别处死2组大鼠各6只。测量牙移动距离并制备组织学切片,行抗酒石酸酸性磷酸酶(TRAP)染色和核因子κB受体活化因子配体(RANKL)免疫组织化学检测。采用SPSS16.0软件包对数据进行统计学分析。结果:骨皮质切开术可在牙移动第1天及3 d后加速正畸牙移动,而牙移动3 d时2组大鼠牙移动距离无显著差异。牙移动第3天和第7天,手术组大鼠压力区破骨细胞数目均显著高于对照组(P<0.05),手术组压力区RANKL的表达也显著高于对照组。结论:骨皮质切开术可加速大鼠正畸牙移动,这可能是由于牙周组织中RANKL高表达介导的破骨增强所致。 PURPOSE: To study the influences of corticotomy on orthodontic tooth movement (OTM) and the underlying mechanism in rats. METHODS: Forty-eight female Sprague-Dawley rats were randomly assigned to corticotomy group (Cort, 24 rats) or sham-corticotomy group (Sham, 24 rats). All rats were subjected OTM after corticotomy or sham surgery. 6 rats of each group were sacrificed at 0, 1, 3 and 7 day of OTM. OTM were measured with an electronic digital caliper. Osteoclasts were counted in pressure side with TRAP. RANKL were measure by IHC at pressure side. The data were analyzed with SPSS 16.0 software package. RESULTS: OTM at the 1 and 7 day in Cort group increased compared with sham group. Number of TRAP positive osteoclasts in pressure side increased in Cort group at the 3 and 7 day. Expression of RANKL in pressure side also increased in Cort group at the 3 and 7 day. CONCLUSIONS: Corticotomy accelerates OTM in rats and it may result from promoted bone resorption via increased RANKL expression in periodontal tissue.
作者 朱绍跃 袁长永 刘宗响 李晓明 王鹏来 ZHU Shao-yue YUAN Chang-yong LIU Zong-xiang LI Xiao-ming WANG Peng-lai(Dental Implant Center, Xuzhou Medical College Affiliated Xuzhou Stomatological Hospital. Xuzhou 221001, Jiangsu Province Xuzhou Medical College School of Stomatology. Xuzhou 221004, Jiangsu Province Faculty of Dentistry, The University of Hong Kong. Hong Kong 999077 Department of Periodontology, Xuzhou Medical College Affiliated Xuzhou Stomatological Hospital. Xuzhou 221002, Jiangsu Province, China)
出处 《上海口腔医学》 CAS CSCD 2017年第1期12-16,共5页 Shanghai Journal of Stomatology
基金 徐州市科技计划项目(KC15SH012)
关键词 骨皮质切开术 牙移动 破骨细胞 RANKL Corticotomy Orthodontic tooth movement Osteoclast RANKL
  • 相关文献

参考文献2

二级参考文献68

  • 1Simonet W S, Lacey D L, Dunstan C R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89(2):309-319
  • 2Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology,1998,139(3):1329-1337
  • 3Tan K B, H arrop J, Reddy M et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene, 1997, 204:35-46
  • 4Kwon BS, Wang S, Udagawa N et al. TR1, a new member of the tumor necrosis factor receptor family,induces fibroblast proliferation and inhibits osteoclastogenesisand bone resorption. FASEB, 1998, 12: 845-854
  • 5Yun T J, Chaudhary P M, Shu G L et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. Journal of Immunology. 1998, 161: 6113-6121
  • 6Yamaguchi K, Kinosaki M, Goto M et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem, 1998, 273(9):5117-5123
  • 7Tomoyasu A, Goto M, Fujise N et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factors. Biochem Biophys Res Com, 1998, 245:382-387
  • 8Tsuda E, Goto M, Mochizuki S I et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochemical and Biophysical Research Communications,1997, 234:137-142
  • 9Bucay N, Sarosi I, Dunstan C R et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev,1998,12:1260-1268
  • 10Malyankar U M, Scatena M, Suchland K L et al. Osteoprotegerin is an αv β3-induced, NF-κ B-dependent survival factor for endothelial cells. J Biol Chem, 2000, 275:20959-20962

共引文献56

同被引文献27

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部